Impact of Specific Oligomeric Supplementation in Oncologic Patients Undergoing Radiotherapy With Malnutrition or at Risk.

Enrolling by invitationOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Malnutrition in ElderlyOncological PatientsDigestive Disorders
Interventions
DIETARY_SUPPLEMENT

Oral supplementation with nutritional oligomeric formula

Patients will be supplemented with the specific oligomeric formula (1 or 2 bottles/day, as per investigator's decision) during, at least, the 12 weeks of the study follow-up.

Trial Locations (4)

Unknown

Hospital Universitario San Juan de Alicante, Alicante

Hospital Universitario Fundación Jiménez Díaz, Madrid

HU Clinica Asturias, Oviedo

Hospital Universitario Son Espases, Palma de Mallorca

Sponsors
All Listed Sponsors
collaborator

Nestlé Health Science Spain

INDUSTRY

lead

Outcomes'10

NETWORK